1. Home
  2. ENVA vs FOLD Comparison

ENVA vs FOLD Comparison

Compare ENVA & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enova International Inc.

ENVA

Enova International Inc.

HOLD

Current Price

$190.01

Market Cap

4.1B

Sector

Finance

ML Signal

HOLD

Logo Amicus Therapeutics Inc.

FOLD

Amicus Therapeutics Inc.

HOLD

Current Price

$14.49

Market Cap

4.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENVA
FOLD
Founded
2011
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
4.5B
IPO Year
2011
2006

Fundamental Metrics

Financial Performance
Metric
ENVA
FOLD
Price
$190.01
$14.49
Analyst Decision
Strong Buy
Buy
Analyst Count
7
9
Target Price
$185.71
$27.25
AVG Volume (30 Days)
184.2K
2.5M
Earning Date
04-23-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
55.05
50.00
EPS
3.46
N/A
Revenue
$3,151,653,000.00
N/A
Revenue This Year
$149.64
$20.50
Revenue Next Year
$16.42
$18.59
P/E Ratio
$54.79
N/A
Revenue Growth
18.58
N/A
52 Week Low
$94.27
$5.66
52 Week High
$191.22
$14.50

Technical Indicators

Market Signals
Indicator
ENVA
FOLD
Relative Strength Index (RSI) 71.71 74.18
Support Level $154.76 $14.21
Resistance Level N/A N/A
Average True Range (ATR) 5.73 0.02
MACD 2.76 -0.00
Stochastic Oscillator 89.76 100.00

Price Performance

Historical Comparison
ENVA
FOLD

About ENVA Enova International Inc.

Enova International Inc provides online financial services, including short-term consumer loans, line of credit accounts, and installment loans to customers mainly in the United States and Brazil. Consumers apply for credit online, the company's technology platforms process the applications, and transactions are completed quickly and efficiently. Its customers are predominantly retail consumers and small businesses. Enova markets its financing products under the names CashNetUSA, NetCredit, OnDeck, Headway Capital, and Simplic. The company also operates a money transfer platform under the name Pangea. Geographically, the company generates a majority of its revenue from its business in the United States and the rest from other international countries.

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a biotechnology company focused to develop and deliver transformative medicines for people living with rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.

Share on Social Networks: